Search results
VBI Vaccine (VBIV) Inks Deal With Agenus for Brain Cancer Study
Zacks via Yahoo Finance· 2 years agoVBI Vaccines (VBIV) enters into a partnership with Agenus to conduct a study evaluating the former's...
VBI Vaccines (VBIV) Down 53% on Initiating Restructuring Plans
Zacks via Yahoo Finance· 1 year agoVBI Vaccines (VBIV) will focus on its HBV vaccine product and advancing its HBV immunotherapeutic...
VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 1 year agoVBI Vaccines, Inc. (VBIV) delivered earnings and revenue surprises of -7.05% and 40.49%,...
VBI Vaccines, Inc. (VBIV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Zacks via Yahoo Finance· 1 year agoVBI Vaccines, Inc. (VBIV) doesn't possess the right combination of the two key ingredients for a...
What Type Of Shareholders Own The Most Number of VBI Vaccines Inc. (NASDAQ:VBIV) Shares?
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in VBI Vaccines Inc. (NASDAQ:VBIV) should be aware of the most powerful shareholder...
VBI Vaccines Announces Cost Cutting Measures, Reverse Stock Split
Benzinga via Yahoo Finance· 1 year agoVBI Vaccines Inc (NASDAQ: VBIV) plans to focus concentrating on broadening access to VBI's...
VBI Vaccines Inc.'s (NASDAQ:VBIV) Intrinsic Value Is Potentially 30% Above Its Share Price
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights The projected fair value for VBI Vaccines is US$3.70 based on 2 Stage Free Cash Flow to...
VBI Vaccines, Agenus Ink Partnership For Combination Brain Cancer Therapy
Benzinga via Yahoo Finance· 2 years agoVBI Vaccines Inc (NASDAQ: VBIV) and Agenus Inc (NASDAQ: AGEN) collaborated to evaluate a combination...
VBI Vaccines Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 1 year agoVBI Vaccines (NASDAQ:VBIV) Full Year 2022 Results Key Financial Results Net loss: US$113.3m (loss...
Why Ocugen, Sorrento Therapeutics, and VBI Vaccines Are on the Move Today
Motley Fool· 2 years agoThe back half of 2022 is already shaping up to be a stock picker's market. Today's mixed trading...